BERLIN, Germany and SEATTLE, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX.F - News) (ISIN:DE000A0BVT96) and Abbott Molecular Inc. (Abbott) today have expand their non-exclusive strategic partnership and amended their collaboration and license agreement in molecular diagnostics closed on September 25, 2007 accordingly.
